These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 387558)

  • 1. [Extension of graft survival time by means of a modification of the treatment with autologous blood].
    Seifert J
    Fortschr Med; 1979 Sep; 97(36):1576-80. PubMed ID: 387558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
    De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
    J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2.
    Gorczynski RM; Fu XM; Issekutz T; Cohen Z
    Cell Immunol; 1998 Feb; 184(1):74-82. PubMed ID: 9626338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.
    Granstein RD; Goulston C; Gaulton GN
    J Immunol; 1986 Feb; 136(3):898-902. PubMed ID: 3079802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of antilymphocyte serum on the antigen-binding cells of the blood and the survival of skin grafts].
    Dinoeva S
    Eksp Med Morfol; 1976; 15(2):89-95. PubMed ID: 776589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
    Sbano P; Cuccia A; Mazzanti B; Urbani S; Giusti B; Lapini I; Rossi L; Abbate R; Marseglia G; Nannetti G; Torricelli F; Miracco C; Bosi A; Fimiani M; Saccardi R
    Arch Dermatol Res; 2008 Mar; 300(3):115-24. PubMed ID: 18259766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of monoclonal anti-H-2Ld and anti-H-2Dd alloantibodies in the immunological enhancement of skin grafts and neonatal heart grafts in the mouse.
    Lems SP; Jacobs CW; Capel PJ; Koene RA
    J Immunol; 1987 Apr; 138(7):2082-7. PubMed ID: 3549896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to immunosuppression in renal transplantation.
    Stuart FP
    Urol Clin North Am; 1976 Oct; 3(3):575-96. PubMed ID: 790732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of ATS and passive and active enhancement on heart and skin allografts in rats.
    Rowiński WA; Wasowska BA; Ryffa T; Stepkowski S; Dabrowski M; Tilney NL; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):809-17. PubMed ID: 6378133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
    Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
    J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
    Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
    Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
    Jansen JL; Koene RA; Kamp GJ; Hagemann JF; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of donor serum to prevent passive transfer of hyperacute rejection.
    Wang J; Geissler EK; Fechner JH; Burlingham WJ; Knechtle SJ
    J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of mouse corpus callosum grafts in neonatal rat recipients, and the effect of host sensitization.
    Pollack IF; Lee LH; Zhou HF; Lund RD
    J Neurosci Res; 1992 Jan; 31(1):33-45. PubMed ID: 1613822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.